mercuronium
Mercuronium is not a recognized pharmaceutical agent in major pharmacological references or regulatory drug catalogs. The name does not appear as an approved medication, and there is no widely documented clinical or pharmacological profile for mercuronium in standard sources. It may represent a misspelling, an obsolete or fictional term, or a misinterpretation of a member of the curonium family of neuromuscular blocking agents.
The suffix -curonium is associated with several established nondepolarizing neuromuscular blockers, including vecuronium, rocuronium, pancuronium, atracurium,
Clinical considerations for neuromuscular blockers in general include cardiovascular effects, potential histamine release (more common with